Quantitative G6PD Deficiency Screening in Routine Malaria Diagnostic Units in the Brazilian Amazon (SAFEPRIM): An Operational Mixed-Methods Study

Background: Glucose-6-phosphate dehydrogenase (G6PD) deficiency testing is not routinely performed before primaquine treatment in most Plasmodium vivax endemic areas, despite the risk of primaquine-associated hemolysis. This is due to the operational challenges associated with pragmatic G6PD testing...

Descripción completa

Detalles Bibliográficos
Autores principales: Brito-Sousa, Jose Diego, Murta, Felipe, Vitor-Silva, Sheila, Sampaio, Vanderson, Mendes, Maxwell, Souza, Brenda, Batista, Talita, Santos, Alicia, Marques, Leonardo, Barbosa, Laila, Balieiro, Patricia, Silva-Neto, Alexandre, Rabello, Renata, Brito, Marcelo, Silva, Emanuelle, Rodovalho, Sheila, Arcanjo, Ana Ruth, Melo, Gisely, Recht, Judith, Domingo, Gonzalo J., Valle, Suiane, Souza, Rodrigo, Nakagawa, Theresa, Monteiro, Wuelton, Lacerda, Marcus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9696723/
https://www.ncbi.nlm.nih.gov/pubmed/36422580
http://dx.doi.org/10.3390/pathogens11111328

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9696723/
https://www.ncbi.nlm.nih.gov/pubmed/36422580
http://dx.doi.org/10.3390/pathogens11111328

Ejemplares similares